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ABSTRACT 
Purpose 
This paper aims to assess whether disability occurrence is related more strongly to proximity to 
death than to age.  
 
Method 
Self reported disability and vital status were available from six annual waves and a subsequent 
12-year mortality follow-up of the Dutch GLOBE longitudinal study. Logit and Poisson 
regression methods were used to study associations of disability occurrence with age and with 
proximity to death. 
 
Results 
For disability in activities of daily living (ADL), regression models with proximity to death had 
better goodness of fit than models with age. With approaching death, the odds for ADL disability 
prevalence and incidence rates increased 20.0% and 18.9% per year, whereas severity increased 
4.1% per year. For the ages younger than 60, 60-69 and older than 70 years, the odds for ADL 
disability prevalence increased 6.4%, 16.0% and 23.0% per year. Among subjects with 
asthma/COPD, heart disease and diabetes increases were 25.1%, 19.5% and 22.72% per year. 
Functional impairments were more strongly related to age. 
 
Conclusions 
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The strong association of (ADL) disability occurrence with proximity to death implies that a 
substantial part of the disability burden may shift to older ages with further increases in life 
expectancy. 
 
INTRODUCTION 
Life expectancy in Western societies has shown substantial increases during the 20th century. In 
the Netherlands, between 1950 and 2005, life expectancy increased with 6.8 years in males and 
with 8.9 years in females [1]. Worldwide, comparable increases in life expectancies occurred 
[2,3]. This trend is not expected to come to an end in the near future. Instead, the average length 
of life is expected to further increase with approximately 5 years between 2005 and 2050 [2-5].  
 
One of the key issues in public health is whether these extra life years gained will be years in 
good health or, otherwise, will be spent in ill health or disability [6-8]. The alternative scenarios 
for future trends in disability occurrence are crucial not only for chances of individual lifelong 
well being [9], but will also influence future demands for health care recourses [10,11].  
 
The future burden of disability among elderly populations may expand at a relative low pace if 
disability occurrence among the elderly would, along with the increasing length of life, shift 
towards ever older ages. The possibility of such a concomitant shift is suggested by end-of-life 
studies showing that trajectories of functional decline may be linked to the end phase of life [12-
19]. As life expectancy increases, trajectories of disability can be expected to at least partially 
shift to older ages. It is uncertain, however, to what extent this would happen. For this, it is 
important to assess to what extent disability occurrence is related to proximity of death (time to 
 3
death) on the one hand and to age (time since birth) on the other hand. To our knowledge, the 
two dimensions of age have not been compared with regards to their relationship to disability 
occurrence. This paper aims to assess whether disability occurrence is related more strongly to 
proximity to death than to age. 
 
This paper is linked to recent health economics research that assessed the extent to which 
increase of life expectancy is likely to increase with health care spending. Several studies 
determined the association of health care costs with age and proximity to death respectively 
[11,20-22]. It was found that health care costs were in part determined by proximity to death and 
that, hence, population ageing is likely to have a more moderate effect on health care spending 
than was previously assumed [11,20-22]. The outcomes of our analysis may help to assess 
whether similar effects may be expected for disability occurrence. 
 
METHODS 
Study population 
We used data from the (GLOBE) study, a prospective cohort study investigating the explanation 
of inequalities in health in the Netherlands [23]. The study comprised a baseline postal survey in 
1991, conducted among a stratified random sample of 27,070 inhabitants of the city of 
Eindhoven (40%) and surrounding municipalities (60%). The age range was set at 15-74 years 
with overrepresentation of 45 years and older. Institutionalized persons were excluded in 
Eindhoven but not in the surrounding municipalities. The response to the baseline questionnaire 
was 70.1% (n=18,973).  
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A subsample (n=3,968) of the initial cohort was invited for an oral interview and received annual 
follow-up questionnaires until 1997 (except for 1996). The subsample overrepresented subjects 
suffering from asthma/chronic obstructive pulmonary disease (COPD), heart disease and 
diabetes mellitus. The response to the oral interview was 72.2% (n=2,867). All analyses in the 
current paper were based on data from the subsample. 
    
The mean age of the subsample at baseline was 52.6 years and 8% of the subjects was disabled 
in their activities of daily living (ADL). At the moment of the last administrative follow-up in 
2004, 16% of the sample had died. Among subjects being ADL disabled at baseline this was 
37% compared to 14% among non-disabled subjects (table 1).  
  
[Insert table 1 about here] 
 
Attrition and item non response  
The maximal number of questionnaires that could have been obtained during follow up of the 
GLOBE subsample was six waves time the 2,867 initial respondents = 17,202 questionnaires. 
However, 3,337 questionnaires were not returned during follow-up, leaving a total of 13,865 
questionnaires.  
 
Among questionnaires that were returned, 403 had incomplete data on disability as measured by 
the Organization for Economic Co-operation and Development (OECD) indicator and 572 had 
incomplete data on ADL disability. Information was missing for only one item on OECD 
disability in 192 cases, and in 226 cases for ADL disability. In these cases, we imputed the 
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missing item with the value of the preceding year or (for 1991) the next year. In total 13,654 
questionnaires with information on OECD disability were available and 13,519 with ADL 
disability information. Information on the presence of asthma/COPD, heart disease and diabetes 
was missing for, respectively, 50, 39 and 62 subjects. 
 
Measures 
As the study results may depend on the type of disability used [24,25], we used different 
disability measures, including a measure based on 10 ADL questions, and a functional limitation 
measure based on 8 questions of the OECD indicator of long-term disabilities [26]. ADL items 
were ‘walking down/up stairs, moving outdoors, leaving/entering house, sitting down/getting up 
from chair, moving on same floor, getting in/out of bed, eating/drinking, getting (un)dressed, 
washing face/hands and washing completely’. OECD items were ‘able to have conversation with 
1 person, able to have conversation with 3 persons or more, reading small letters, recognizing 
faces, biting/chewing  food, carry 5 kilo for 10 meter, bending/take something from ground, 
walking 400 meter’.  
 
For each ADL and OECD item, subjects were asked whether they were able to perform the 
actions ‘without difficulty’, ‘with minor difficulty’, ‘with major difficulty’, ‘not able to 
perform/only with help’. Disability was defined as having at least one item answered with ‘with 
major difficulty’ or ‘not able to perform/only with help’. In sensitivity analyses, we also applied 
an alternative cut-off point to define prevalence cases, as those who had at least two (instead of 
one) items with ‘with major difficulty’ or ‘not able to perform/only with help’  
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 Information on age, sex and presence of asthma/COPD, heart disease and diabetes mellitus was 
obtained from the baseline survey. Table 1 presents baseline characteristics of all respondents 
and of those who died during follow-up.  
 
Data analysis 
The variables ‘prevalence’, ‘incidence’, ‘severity’ and ‘proximity to death’ were created for the 
six waves of data collection separately. ‘Prevalence’ indicated whether disability was reported at 
the time the data were collected. An individual was considered ‘incident’ if disability existed in 
the year of observation but was absent in the preceding year. For all cases of disability, ‘severity’ 
was calculated by counting the case in which respondents reported having ‘much difficulty’, 
‘no/just with help’. ‘Proximity to death’ was calculated as the difference between the moment of 
death, available from linkage to population registers, and the moment of the survey.  
 
For all statistical analysis, Stata 10.0 was used. Generalized Estimating Equations (GEE) models 
were used to account for the interdependence of observations from one individual. Prevalence 
data were analyzed using logistic regression analysis, while incidence and severity data were 
analyzed using Poisson regression. Dependent variables were ‘prevalence’, ‘incidence’ and 
‘severity’ and independent variables were ‘age’, ‘proximity to death’ and ‘sex’. A dichotomous 
variable was added to the models indicating whether or not subjects had died during follow-up, 
and to capture differences in disability between those who died and those who survived until the 
end of follow-up. Consequently, the relationship of disability to proximity to death could be 
estimated only from subjects who died during follow-up.  
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 Stratifications were applied according to age (younger than 60, 60-69 and older than 70 years) 
and presence of a chronic disease (asthma/COPD, heart disease and diabetes mellitus). To 
indicate the goodness of fit of the models wald chi2 values were calculated.  
 
RESULTS 
Figure 1 presents ADL prevalence, incidence and severity rates by 5 year age groups and by time 
to death. Disability prevalence increased from around 0.05 up to 0.35 in the oldest age category 
of 80-84 years. In relationship to proximity to death, disability prevalence increased from 0.12, 
12 years prior to death, to 0.38 in the year prior to death.  Increases of disability incidence were 
more pronounced with approaching death as compared to increasing age. The maximum value of 
disability incidence was 0.10 at the highest age group as compared to 0.26 within the year prior 
to death. Increases of severity also were more pronounced with approaching death. Severity was 
especially high the last four years prior to death.   
 
[Insert figure 1 about here] 
 
Table 2 presents wald chi2 values that express the goodness of fit of regression models with, 
respectively, age, proximity to death and these two factors combined. For OECD disability 
prevalence and incidence, goodness of fit values were higher for the age model (350 and 129) as 
compared to the proximity to death model (220 and 80) indicating a closer relationship of OECD 
disability with age. ADL disability, on the other hand, showed goodness of fit values higher for 
models with proximity to death (309 and 198) as to models with age (187 and 64), indicating that 
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ADL disability was more closely associated with proximity to death. For severity of disability, 
goodness of fit values were the highest for models with proximity to death, for both OECD and 
ADL disability.  
 
The regression coefficients in table 2 show that increases of both OECD and ADL disability 
prevalence were higher with increasing proximity to death (7.1 and 20.0) as compared to 
increases with age (4.3 and 4.7). Increases of incidence and severity were also higher with 
increasing proximity to death as compared to increases with age, for both ADL and OECD 
disability.  
 
An additional analysis, defining disability as having at least two (instead of one) items with 
‘much difficulty’ or ‘no/just with help’, showed goodness of fit values of 350 (age model) and 
220 (proximity to death model) for OECD prevalence and 187 (age model) and 309 (proximity 
to death model) for ADL prevalence and values. Thus, using a more strict definition of disability 
showed more clearly a stronger association with age for OECD disability and a stronger 
association with proximity to death than with age, for ADL disability.  
 
[Insert table 2 about here] 
 
In table 3, goodness of fit values are presented for models with age and proximity to death 
among groups of patients with asthma/COPD, heart disease and diabetes. Similar estimates are 
also presented for people without any of these diseases.  For all groups with a chronic disease, 
the prevalence of ADL disability showed a better fit with proximity to death than with age. For 
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the prevalence of OECD disability in heart disease and diabetes patients, the goodness of fit was 
similar with age as with proximity to death, whereas for asthma/COPD patients the best fit was 
with age. With approaching death, increases of prevalence of ADL disability varied from 19.5 in 
heart disease patients to 25.1 in asthma/COPD patients. Increases in OECD disability prevalence 
varied from 4.6 in heart disease patients to 11.6 in asthma/COPD patients. Increases with age 
were lower and varied from 4.7 to 6.3 for ADL disability and from 4.0 to 4.4 for OECD 
disability. 
 
[Insert table 3 about here] 
 
Figure 2 presents estimates of the prevalence of ADL disability over the last twelve years of life 
for asthma/COPD, heart disease and diabetes patients calculated from regression models 
including proximity to death, age and sex. For the calculations, a constant age of 70 years was 
assumed and sex was set as the average of values for male and female. The dichotomous variable 
indicating whether subjects from the original dataset had died at the end of follow-up (1) or 
where still alive (0) was set at 0.5. From 12 years prior to death to the year prior to death, 
disability prevalence increased from around 0.10 up to 0.48 in diabetes patients, up to 0.54 in 
patients with heart disease and up to 0.60 in patients with asthma/COPD.  
 
[Insert figure 2 about here] 
 
Table 4 presents wald chi2 values that express the goodness of fit of regression models for 
different age strata and for males and females separately and combined. For ADL disability 
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prevalence, goodness of fit values were higher for the oldest age category (110), as compared to 
the youngest age category (67). The goodness of fit for OECD disability was better for the 
youngest age category (172) as compared to the oldest age category (24). This pattern was not 
different for males and females.  
 
The regression coefficients in table 4 show that increases of the prevalence of ADL disability 
with approaching death were stronger in the oldest age category (23.0) as compared to the 
youngest age category (6.4), also for males and females separately. Increases of OECD disability 
were also higher for the oldest age category (7.5) as compared to the youngest age category 
(6.3).  
 
[Insert table 4 about here] 
 
Figure 3 presents estimates of the prevalence of ADL disability over the last twelve years of life 
for age strata younger then 60 years, 60-69 years and older than 70 years, calculated from 
regression models including proximity to death, age and sex. For the calculations, a constant age 
of 55, 65 and 75 years was assumed for the respective age categories. Sex and the value 
indicating death at the end of follow-up were set identical as was done for figure 2. From 12 
years prior to death to the year prior to death, disability prevalence increased from below 0.15 up 
to 0.25 for ages younger than 60 years, up to 0.39 for ages 60-69 years and up to 0.59 for ages 
older than 70 years.  
 
[Insert figure 3 about here] 
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 DISCUSSION 
Summary of results 
The concept of proximity to death dependence has widely been applied in the health economical 
field and has led to important new insights in expectations of future health care expenditures. 
Previous research suggested that disability occurrence is also partly related to approaching death. 
However, no previous study compared age and proximity to death with regards to their 
associations with disability occurrence. Our results showed that ADL disability was more 
strongly related to proximity to death than to age, also within specific patient groups and among 
different age groups. Functional impairments, as measured with the OECD list, were however 
more strongly related to age. 
 
Evaluation of data and methods 
Our data has some limitations that need proper attention. If non-response during follow-up was 
related to disability occurrence, this may have influenced the estimation of proximity to death 
parameters. To evaluate this possibility of attrition bias, we compared mortality during follow-up 
between non-responders and the rest of the study population. Age-standardized mortality among 
non-responders was 12.9% versus 16.4% among the rest of the population. The lower mortality 
ratio among non-responders could be indicative of a lower disability prevalence among this 
group. In order to evaluate whether this might have biased our estimates of proximity to death 
dependence, we compared the original prevalence plots with plots in which missing disability 
values imputed from last available observations. The new plots hardly differed from the original 
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plots. The relatively unchanged plots indicate that bias related to sample attrition or item non 
response is probably small.  
 
Opposite to the (small) effect of attrition in our study, exclusion of part of the institutionalized 
population from the baseline survey could have been associated with a lower prevalence of 
disability due to exclusion of the relatively more disabled nursing home population. As 
admission to a nursing home occurs often at the end of life, exclusion of the institutionalized 
might have led to some degree of underestimation of the proximity to death dependence of 
disability.  
 
The use of self-reported measures of disease and disability might have led to some information 
bias. This would particularly be problematic if, independent from the status of disability, 
reporting behavior was related to proximity to death. With the available data, these effects cannot 
be studied, and, as far as we know, no studies exist that describe such effects. One could imagine 
that being in the last phase of life could both positively (by increased relativism) and negatively 
(by increased pessimism) affect one’s perception and reporting of disability. If the latter, 
pessimistic tendency were to predominate, this could in part explain the relationship with 
proximity to death observed in this study. Nevertheless, as the significant increases of health care 
costs the last years of life [11,20-22] are to at least some extent related to disability occurrence 
[27,28], it seems unlikely that reporting tendencies alone would explain much of this strong 
increase in disability occurrence. 
 
Comparison to previous studies 
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Our finding that disability prevalence increases as death approaches is in general agreement with 
a substantial amount of literature reporting terminal trajectories of functional decline at the end 
of life [12-19]. Similar to our results, trajectories of functional decline were also reported among 
terminal patients with different diseases [12,17,19], e.g. COPD, diabetes and cerebrovascular 
accident [19]. In line with our finding of a stronger association of disability prevalence with 
proximity to death at older ages, it was found that disability rates prior to death were higher at 
increased ages of death [15]. Hubert et al. [29] found increasing disability scores with 
approaching death as from 10 years prior to death. As with our finding of a relationship over 12 
years of time, their results suggest that death casts its shadow remotely over life. 
 
In the health economics field, the principle of relating health care expenditures to proximity to 
death has been applied for more than 20 years [28]. International studies found that health care 
expenditures during the last year of life are four to six times higher than expenditures for 
survivors [22,27] and ten times higher compared to expenditures five years earlier before death 
[21]. In the Netherlands, 10% of total health expenditure has been found to be associated with 
health care use during the last year of life [20]. To compare, we calculated the share of lifetime 
ADL disability burden (prevalence times severity) that occurred during the last year of life and 
during the last five years of life, assuming an 80 years lifespan. We estimated that 18% of the 
lifetime disability burden would occur during the last year of life and 66% of the burden would 
occur during the last five years of life. This suggests that ADL disability burden is at least as 
strongly related to the end of life as health care costs.  
 
Interpretations of other findings  
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A remarkable difference was observed between the dominant proximity to death dependence of 
ADL disability on the one hand and the dominant age dependence of functional impairments (as 
measured in the OECD measure) on the other hand. This difference may perhaps be explained to 
the different physical domains that these scales represent: ADL mainly represents the locomotory 
domain, and functional impairments also represent visual, auditive and lingual domains. Ageing 
is associated with degeneration and lack of maintenance and repair of physiological and 
metabolic systems [30-32]. As a result of damage to these systems, disability can occur, and, if a 
life maintaining system is involved, chances for death increase. As compared to ADL disability, 
functional impairments as measured in the OECD list may be more associated to damage to 
systems that are not life maintaining (e.g. hearing and vision) and that therefore are more 
dependent on age.  
 
Our finding that the prevalence of disability is more strongly associated to proximity to death in 
males as compared to females may be explained by the fact that females tend to suffer to a larger 
extent from non-lethal chronic disabling conditions like arthritis and back complaints [33-36] 
whereas lethal disabling conditions like cardiovascular disease and cancer are more common in 
males [33-36].  
 
Implications 
Current projection models of the future prevalence of disability either assume that age specific 
prevalence rates are constant or that past trends in age-specific disability prevalence rates will 
continue at the same rate in the future [37]. Scenarios for health care expenditures show that age 
based models overestimate future expenditures as compared to models that take into account 
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dependence on proximity to death. The latter models project about 10% less increase. [20]. Our 
preliminary estimates for the Netherlands suggested that disability burden are about equally 
related to the last year of life as health care expenditures. This would imply that projection 
models that would take into account this dependence on proximity to death would modify future 
projection to a similar extent as projections of health care expenditures.  
 
Estimating to what extent past disability trends will be prolonged in the future remains a difficult 
exercise. In order to improve projections, we strongly recommend incorporating proximity of 
death parameters in future projection models. This would enable to directly relate future 
disability occurrence to expectations of increasing life expectancy [2-5] and could therefore lead 
to importantly improved estimations. The different results for ADL disability and for functional 
impairments, plea for incorporation of multiple domains of disability in projections of future 
trends in disability burden.  
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Table 1 
Baseline characteristics of respondents and deaths during follow-up 
 Respondents Deaths before end of follow-up 
 
No. 
subjects 
% Mean age SD
No. with 
ADL 
disability 
% 
No. among 
all subjects 
% 
No. among 
baseline 
ADL disabled 
% 
No. among 
baseline 
ADL non-
disabled 
% 
All 2867 100  52.6 14.1  241 8  468 16  88 37  380 14 
                  
<60 yrs 1888 66  45.4 0.3  112 6  128 7  22 20  106 6 
                  
60-69 yrs 748 26  64.7 0.1  92 12  222 30  45 49  177 27 
                  
>=70 yrs 231 8  72 0.2  37 16  118 51  21 57  97 50 
                  
Asthma/COPD 588 21  53.1 0.7  75 13  147 25  33 44  114 22 
                  
Heart disease 446 16  61.4 0.4  71 16  178 40  40 56  138 37 
                  
Diabetes 262 9  60.2 0.6  36 14  92 35  20 56  72 32 
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Table 2 
Goodness of fit and regression coefficients of models relating disability to age and proximity to 
death 
  Goodness of fit (wald chi2) Regression estimate (% increase per year) 
  age 
proximity to 
death 
age + 
proximity to 
death 
age 95% CI 
proximity to 
death 
95% CI 
Prevalence ADL 187 309 359 4.7 3.7, 5.7 20.0 14.8, 25.4 
 OECD 350 220 424 4.3 3.7, 4.8 7.1 3.7, 10.7 
         
Incidence ADL 64 198 214 2.7 1.6, 3.8 18.9 10.4, 28.0 
 OECD 129 80 169 2.9 2.4, 3.6 11.2 4.9, 18.0 
         
Severity ADL 22 44 50 0.6 0.1,1.2 4.1 1.9, 6.3 
 OECD 77 162 181 0.8 0.5, 1.2 4.7 3.4, 6.1 
Note. Separate sex-adjusted models were fit for ADL and OECD disability. Goodness of fit is 
represented for three separate models, the regression estimates come from one model with ‘age’ 
and ‘proximity to death’.  
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Table 3 
Goodness of fit and regression coefficients of models relating disability to age and proximity to 
death, stratified to chronic disease 
  Goodness of fit (wald chi2) Regression estimate (% increase per year) 
  age 
proximity to 
death 
age + 
proximity to 
death 
age 95% CI 
proximity to 
death 
95% CI 
Asthma/COPD ADL 66 107 126 5.7 3.8, 7.6 25.1 16.4, 34.5 
 OECD 101 78 128 4.4 3.3, 5.6 11.6 5.4, 18.1 
         
Heart disease ADL 46 86 94 4.7 2.1, 7.4 19.5 11.9, 27.6 
 OECD 43 44 62 4.1 2.3, 5.9 4.6 -1.1, 10.7 
         
Diabetes ADL 25 39 45 6.3 2.8, 9.9 22.7 10.1, 36.7 
 OECD 24 23 35 4.0 1.8, 6.2 9.0 1.0, 17.7 
         
No disease ADL 47 51 76 3.8 2.4, 5.1 11.0 1.4, 21.6 
 OECD 145 48 155 4.0 3.2, 4.7 3.5 -2.9, 10.4 
Note. Separate sex-adjusted models were fit for ADL and OECD disability. Goodness of fit is 
represented for three separate models, the regression estimates come from one model with ‘age’ 
and ‘proximity to death’.  
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Table 4 
Goodness of fit and regression coefficients of models relating disability prevalence to proximity 
to death, stratified to age categories 
  Goodness of fit (wald chi2) Regression estimate proximity to death (% increase per year) 
  
male + 
female 
male female 
male + 
female 
95% CI male 95% CI female 95% CI 
All  ADL 343 204 176 19.1 13.9, 24.4 27.0 19.1, 35.3 14.2 7.2, 21.6 
 OECD 394 218 194 7.8 6.0, 9.7 7.3 2.9, 11.9 6.6 1.2, 12.4 
           
<60  yrs ADL 67 40 28 6.4 -3.2, 17.0 9.5 -3.3, 24.0 3.1 -10.9, 19.3 
 OECD 172 83 92 6.3 -1.3, 14.5 5.4 -4.4, 16.2 8.0 -3.8, 21.1 
           
60-69 yrs ADL 66 62 19 16.0 8.3, 24.3 24.3 12.8, 37.0 6.6 -3.6, 17.9 
 OECD 38 42 9 6.4 1.1, 11.9 7.1 0.6, 14.1 6.3 -2.6, 15.9 
           
>=70 yrs ADL 110 73 53 23.0 13.9, 32.7 38.1 21.4, 57.1 17.2 6.2, 29.3 
  OECD 24 20 9 7.5 1.6, 13.6 10.0 1.7, 19.0 7.0 -1.6, 16.3 
Note. Separate age and sex-adjusted models were fit for ADL and OECD disability. Goodness of 
fit and regression estimates are represented for separate models including both males and 
females, males only and females only.  
 
 
 
 25
Figure 1 Prevalence, incidence and severity of ADL disability by age and time to death 
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Figure 2 Regression based estimates of ADL disability prevalence by time to death stratified by 
chronic disease 
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Figure 3 Regression based estimates of ADL disability prevalence by time to death stratified by 
age 
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